leucine has been researched along with Facies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzai, M; Aoki, Y; Endo, W; Haginoya, K; Inui, T; Kikuchi, A; Kure, S; Miyabayashi, T; Nagai, K; Niihori, T; Okubo, Y; Sato, R; Suzuki-Muromoto, S; Takezawa, Y; Togashi, N; Yamamura-Suzuki, S | 1 |
1 other study(ies) available for leucine and Facies
| Article | Year |
|---|---|
Leucine-485 deletion variant of BRAF may exhibit the severe end of the clinical spectrum of CFC syndrome.
Topics: Amino Acid Sequence; Child, Preschool; Ectodermal Dysplasia; Facies; Failure to Thrive; Heart Defects, Congenital; Humans; Leucine; Male; Proto-Oncogene Proteins B-raf; Sequence Deletion; Severity of Illness Index | 2019 |